vs
Side-by-side financial comparison of Solventum (SOLV) and Petco Health & Wellness Company, Inc. (WOOF). Click either name above to swap in a different company.
Solventum is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.4× Petco Health & Wellness Company, Inc.). Solventum runs the higher net margin — 0.6% vs 0.6%, a 0.0% gap on every dollar of revenue. On growth, Solventum posted the faster year-over-year revenue change (-3.0% vs -3.1%). Petco Health & Wellness Company, Inc. produced more free cash flow last quarter ($60.6M vs $-273.0M). Over the past eight quarters, Solventum's revenue compounded faster (-1.8% CAGR vs -6.5%).
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
Petco Health and Wellness Company, Inc. is an American pet retailer with corporate offices in San Diego and San Antonio. Petco sells pet food, products, and services, as well as certain types of live small animals.
SOLV vs WOOF — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.5B |
| Net Profit | $13.0M | $9.3M |
| Gross Margin | 54.7% | 38.9% |
| Operating Margin | 4.0% | 2.0% |
| Net Margin | 0.6% | 0.6% |
| Revenue YoY | -3.0% | -3.1% |
| Net Profit YoY | — | 156.0% |
| EPS (diluted) | $0.07 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $1.5B | ||
| Q3 25 | $2.1B | $1.5B | ||
| Q2 25 | $2.2B | $1.5B | ||
| Q1 25 | $2.1B | $1.6B | ||
| Q4 24 | $2.1B | $1.5B | ||
| Q3 24 | $2.1B | $1.5B | ||
| Q2 24 | $2.1B | $1.5B |
| Q1 26 | $13.0M | — | ||
| Q4 25 | $63.0M | $9.3M | ||
| Q3 25 | $1.3B | $14.0M | ||
| Q2 25 | $90.0M | $-11.7M | ||
| Q1 25 | $137.0M | $-13.8M | ||
| Q4 24 | $31.0M | $-16.7M | ||
| Q3 24 | $122.0M | $-24.8M | ||
| Q2 24 | $89.0M | $-46.5M |
| Q1 26 | 54.7% | — | ||
| Q4 25 | 51.4% | 38.9% | ||
| Q3 25 | 54.2% | 39.3% | ||
| Q2 25 | 54.4% | 38.2% | ||
| Q1 25 | 53.8% | 38.0% | ||
| Q4 24 | 53.9% | 38.1% | ||
| Q3 24 | 56.0% | 38.1% | ||
| Q2 24 | 54.6% | 37.8% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 6.3% | 2.0% | ||
| Q3 25 | 80.6% | 2.9% | ||
| Q2 25 | 9.9% | 1.1% | ||
| Q1 25 | 7.3% | 1.1% | ||
| Q4 24 | 6.6% | 0.3% | ||
| Q3 24 | 13.2% | 0.2% | ||
| Q2 24 | 11.7% | -1.1% |
| Q1 26 | 0.6% | — | ||
| Q4 25 | 3.2% | 0.6% | ||
| Q3 25 | 60.4% | 0.9% | ||
| Q2 25 | 4.2% | -0.8% | ||
| Q1 25 | 6.6% | -0.9% | ||
| Q4 24 | 1.5% | -1.1% | ||
| Q3 24 | 5.9% | -1.6% | ||
| Q2 24 | 4.3% | -3.0% |
| Q1 26 | $0.07 | — | ||
| Q4 25 | $0.37 | $0.03 | ||
| Q3 25 | $7.22 | $0.05 | ||
| Q2 25 | $0.51 | $-0.04 | ||
| Q1 25 | $0.78 | $-0.05 | ||
| Q4 24 | $0.18 | $-0.06 | ||
| Q3 24 | $0.70 | $-0.09 | ||
| Q2 24 | $0.51 | $-0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $561.0M | $237.4M |
| Total DebtLower is stronger | $4.6B | — |
| Stockholders' EquityBook value | $5.0B | $1.2B |
| Total Assets | $14.1B | $5.2B |
| Debt / EquityLower = less leverage | 0.92× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $561.0M | — | ||
| Q4 25 | $878.0M | $237.4M | ||
| Q3 25 | $1.6B | $188.7M | ||
| Q2 25 | $492.0M | $133.3M | ||
| Q1 25 | $534.0M | $165.8M | ||
| Q4 24 | $762.0M | $116.7M | ||
| Q3 24 | $772.0M | $127.6M | ||
| Q2 24 | $897.0M | $89.7M |
| Q1 26 | $4.6B | — | ||
| Q4 25 | $5.0B | — | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $7.8B | — | ||
| Q1 25 | $7.9B | — | ||
| Q4 24 | $8.0B | — | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $8.3B | — |
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $1.2B | ||
| Q3 25 | $5.0B | $1.1B | ||
| Q2 25 | $3.6B | $1.1B | ||
| Q1 25 | $3.3B | $1.1B | ||
| Q4 24 | $3.0B | $1.1B | ||
| Q3 24 | $3.2B | $1.1B | ||
| Q2 24 | $2.9B | $1.2B |
| Q1 26 | $14.1B | — | ||
| Q4 25 | $14.3B | $5.2B | ||
| Q3 25 | $14.0B | $5.2B | ||
| Q2 25 | $15.1B | $5.1B | ||
| Q1 25 | $14.5B | $5.2B | ||
| Q4 24 | $14.5B | $5.2B | ||
| Q3 24 | $14.7B | $5.3B | ||
| Q2 24 | $14.6B | $5.3B |
| Q1 26 | 0.92× | — | ||
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.14× | — | ||
| Q1 25 | 2.43× | — | ||
| Q4 24 | 2.71× | — | ||
| Q3 24 | 2.54× | — | ||
| Q2 24 | 2.90× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $90.1M |
| Free Cash FlowOCF − Capex | $-273.0M | $60.6M |
| FCF MarginFCF / Revenue | -13.6% | 4.1% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | — | 9.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-203.0M | $129.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $95.0M | $90.1M | ||
| Q3 25 | $76.0M | $85.9M | ||
| Q2 25 | $169.0M | $-15.5M | ||
| Q1 25 | $29.0M | $96.0M | ||
| Q4 24 | $219.0M | $20.7M | ||
| Q3 24 | $169.0M | $69.4M | ||
| Q2 24 | $355.0M | $-8.4M |
| Q1 26 | $-273.0M | — | ||
| Q4 25 | $32.0M | $60.6M | ||
| Q3 25 | $-21.0M | $53.8M | ||
| Q2 25 | $59.0M | $-43.9M | ||
| Q1 25 | $-80.0M | $59.0M | ||
| Q4 24 | $92.0M | $-10.3M | ||
| Q3 24 | $76.0M | $42.0M | ||
| Q2 24 | $297.0M | $-41.1M |
| Q1 26 | -13.6% | — | ||
| Q4 25 | 1.6% | 4.1% | ||
| Q3 25 | -1.0% | 3.6% | ||
| Q2 25 | 2.7% | -2.9% | ||
| Q1 25 | -3.9% | 3.8% | ||
| Q4 24 | 4.4% | -0.7% | ||
| Q3 24 | 3.7% | 2.8% | ||
| Q2 24 | 14.3% | -2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | 2.0% | ||
| Q3 25 | 4.6% | 2.2% | ||
| Q2 25 | 5.1% | 1.9% | ||
| Q1 25 | 5.3% | 2.4% | ||
| Q4 24 | 6.1% | 2.1% | ||
| Q3 24 | 4.5% | 1.8% | ||
| Q2 24 | 2.8% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 1.51× | 9.66× | ||
| Q3 25 | 0.06× | 6.15× | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 7.06× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | 3.99× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SOLV
| Infection Prevention and Surgical Solutions | $737.0M | 37% |
| Advanced Wound Care | $497.0M | 25% |
| Dental Solutions | $354.0M | 18% |
| Health Information Systems | $342.0M | 17% |
| All Other 4 | $76.0M | 4% |
WOOF
| Consumables | $731.5M | 50% |
| Supplies And Companion Animals | $478.1M | 33% |
| Services & Other | $254.8M | 17% |
